BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sen MK, Almuslehi MSM, Shortland PJ, Coorssen JR, Mahns DA. Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse? Front Immunol 2020;11:572186. [PMID: 33117365 DOI: 10.3389/fimmu.2020.572186] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Temmerman J, Van Der Veken F, Engelborghs S, Guldolf K, Nagels G, Smeets D, Allemeersch GJ, Costers L, D'hooghe MB, Vanbinst AM, Van Schependom J, Bjerke M, D'haeseleer M. Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity. J Clin Med 2022;11:523. [PMID: 35159972 DOI: 10.3390/jcm11030523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dziedzic A, Saluk-Bijak J, Miller E, Niemcewicz M, Bijak M. The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis. Int J Mol Sci 2021;22:1804. [PMID: 33670394 DOI: 10.3390/ijms22041804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Sen MK, Almuslehi MSM, Shortland PJ, Mahns DA, Coorssen JR. Proteomics of Multiple Sclerosis: Inherent Issues in Defining the Pathoetiology and Identifying (Early) Biomarkers. Int J Mol Sci 2021;22:7377. [PMID: 34298997 DOI: 10.3390/ijms22147377] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Pachner AR. The Neuroimmunology of Multiple Sclerosis: Fictions and Facts. Front Neurol 2022;12:796378. [DOI: 10.3389/fneur.2021.796378] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sen MK, Hossain MJ. Oligodendrocyte-Specific Mechanisms of Myelin Thinning: Implications for Neurodegenerative Diseases. Front Neurosci 2021;15:663053. [PMID: 33841096 DOI: 10.3389/fnins.2021.663053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Elbini-dhouib I, Manai M, Neili N, Marzouki S, Sahraoui G, Ben Achour W, Zouaghi S, Benahmed M, Doghri R, Srairi-abid N. Dual Mechanism of Action of Curcumin in Experimental Models of Multiple Sclerosis. IJMS 2022;23:8658. [DOI: 10.3390/ijms23158658] [Reference Citation Analysis]
7 Meijer M, Agirre E, Kabbe M, van Tuijn CA, Heskol A, Zheng C, Mendanha Falcão A, Bartosovic M, Kirby L, Calini D, Johnson MR, Corces MR, Montine TJ, Chen X, Chang HY, Malhotra D, Castelo-branco G. Epigenomic priming of immune genes implicates oligodendroglia in multiple sclerosis susceptibility. Neuron 2022. [DOI: 10.1016/j.neuron.2021.12.034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sobel RA, Albertelli M, Hinojoza JR, Eaton MJ, Grimes KV, Rubenstein E. Azetidine-2-Carboxylic Acid-Induced Oligodendrogliopathy: Relevance to the Pathogenesis of Multiple Sclerosis. J Neuropathol Exp Neurol 2022;81:414-33. [PMID: 35521963 DOI: 10.1093/jnen/nlac028] [Reference Citation Analysis]
9 Doskas T, Dardiotis E, Vavougios GD, Ntoskas KT, Sionidou P, Vadikolias K. Stroke risk in multiple sclerosis: a critical appraisal of the literature. International Journal of Neuroscience. [DOI: 10.1080/00207454.2022.2056459] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hashem M, Shafqat Q, Wu Y, Rho JM, Dunn JF. Abnormal Oxidative Metabolism in the Cuprizone Mouse Model of Demyelination: an in vivo NIRS-MRI Study. Neuroimage 2022;:118935. [PMID: 35091079 DOI: 10.1016/j.neuroimage.2022.118935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ullah F, Gamage R, Sen MK, Gyengesi E. The Effects of Modified Curcumin Preparations on Glial Morphology in Aging and Neuroinflammation. Neurochem Res 2022. [PMID: 34988899 DOI: 10.1007/s11064-021-03499-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tavares GA, Louveau A. Meningeal Lymphatics: An Immune Gateway for the Central Nervous System. Cells 2021;10:3385. [PMID: 34943894 DOI: 10.3390/cells10123385] [Reference Citation Analysis]
13 Onisiforou A, Spyrou GM. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches. Brief Bioinform 2021:bbab141. [PMID: 34237135 DOI: 10.1093/bib/bbab141] [Reference Citation Analysis]
14 Sen MK, Mahns DA, Coorssen JR, Shortland PJ. The roles of microglia and astrocytes in phagocytosis and myelination: Insights from the cuprizone model of multiple sclerosis. Glia 2022. [PMID: 35107839 DOI: 10.1002/glia.24148] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Almuslehi MSM, Sen MK, Shortland PJ, Mahns DA, Coorssen JR. Histological and Top-Down Proteomic Analyses of the Visual Pathway in the Cuprizone Demyelination Model. J Mol Neurosci. [DOI: 10.1007/s12031-022-01997-w] [Reference Citation Analysis]